Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MD 
Mednax Inc (MD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: MD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $16.71
1 Year Target Price $16.71
| 3 | Strong Buy |
| 0 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -1.58% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.35B USD | Price to earnings Ratio 11.95 | 1Y Target Price 16.71 |
Price to earnings Ratio 11.95 | 1Y Target Price 16.71 | ||
Volume (30-day avg) 8 | Beta 1.21 | 52 Weeks Range 10.06 - 17.67 | Updated Date 08/15/2025 |
52 Weeks Range 10.06 - 17.67 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.3 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-05 | When - | Estimate 0.42 | Actual 0.53 |
Profitability
Profit Margin 5.66% | Operating Margin (TTM) 13.59% |
Management Effectiveness
Return on Assets (TTM) 6.5% | Return on Equity (TTM) 14.27% |
Valuation
Trailing PE 11.95 | Forward PE 9.45 | Enterprise Value 1651038898 | Price to Sales(TTM) 0.7 |
Enterprise Value 1651038898 | Price to Sales(TTM) 0.7 | ||
Enterprise Value to Revenue 0.85 | Enterprise Value to EBITDA 8.11 | Shares Outstanding 87084200 | Shares Floating 84230916 |
Shares Outstanding 87084200 | Shares Floating 84230916 | ||
Percent Insiders 2.19 | Percent Institutions 96.12 |
Upturn AI SWOT
Mednax Inc
Company Overview
History and Background
Mednax, Inc. was founded in 1979 as a physician practice management company specializing in neonatal, maternal-fetal, and pediatric services. It expanded through acquisitions to become a national provider of these services. The company has since rebranded and broadened its service offerings.
Core Business Areas
- Neonatology: Management and staffing of neonatal intensive care units (NICUs), providing care for premature and critically ill newborns.
- Maternal-Fetal Medicine: Services focused on high-risk pregnancies, including consultations, diagnostic testing, and management of complications.
- Pediatrics: General and specialized pediatric care, including hospital-based and outpatient services.
- Anesthesiology: Anesthesia services across different areas of healthcare.
Leadership and Structure
The leadership team consists of the CEO, CFO, COO, and other key executives. The organizational structure is hierarchical, with regional divisions and service line leaders.
Top Products and Market Share
Key Offerings
- Neonatal Intensive Care Unit (NICU) Management: Comprehensive management and staffing of NICUs. Market share is difficult to pinpoint precisely, but Mednax holds a significant position as one of the largest providers. Competitors include Pediatrix Medical Group, Envision Healthcare, and various hospital systems offering their own NICU services. Data on revenue attributed solely to NICU management is not publicly available.
- Maternal-Fetal Medicine (MFM) Services: Specialized care for high-risk pregnancies. Market share data is fragmented due to regional variations and hospital-based programs. Competitors include academic medical centers, large hospital systems, and other physician groups. Revenue from MFM services is not typically reported separately.
- Anesthesia Services: Full service anesthesiology management, operations, and clinical practice. Competitors include North American Partners in Anesthesia (NAPA) and Envision Healthcare.
Market Dynamics
Industry Overview
The healthcare services industry is characterized by increasing demand, cost pressures, regulatory changes, and consolidation. Demand for specialized pediatric and maternal-fetal services is growing due to advancements in medical technology and an aging population.
Positioning
Mednax is positioned as a large, national provider of specialized physician services. Its competitive advantages include scale, expertise in managing physician practices, and established relationships with hospitals.
Total Addressable Market (TAM)
The TAM for outsourced physician services in the US is estimated to be in the tens of billions of dollars annually. Mednax captures a portion of this TAM through its various service lines. Exact TAM is not publicly available.
Upturn SWOT Analysis
Strengths
- National Scale
- Established Relationships with Hospitals
- Expertise in Physician Practice Management
- Strong Brand Recognition
Weaknesses
- High Debt Levels
- Dependence on Acquisitions for Growth
- Integration Challenges with Acquired Practices
- Exposure to Reimbursement Rate Changes
Opportunities
- Expansion into New Geographic Markets
- Development of New Service Lines
- Increased Adoption of Telehealth Services
- Strategic Partnerships with Accountable Care Organizations (ACOs)
Threats
- Changes in Healthcare Regulations and Reimbursement Rates
- Increased Competition from Other Physician Practice Management Companies
- Rising Operating Costs
- Economic Downturn
Competitors and Market Share
Key Competitors
- EVHC
- USPH
Competitive Landscape
Mednax/Pediatrix competes on scale, expertise, and relationships with hospitals. Advantages include its national network and established reputation. Disadvantages may include high debt levels and integration challenges.
Major Acquisitions
Obstetrix Medical Group
- Year: 2007
- Acquisition Price (USD millions): 760
- Strategic Rationale: Expanded Mednax's maternal-fetal medicine services and geographic reach.
Growth Trajectory and Initiatives
Historical Growth: Mednax, now Pediatrix, has historically grown through acquisitions and organic growth in its core service lines. Growth has varied due to industry challenges and strategic shifts.
Future Projections: Analyst estimates for PDX would be required to project future growth, considering factors like market trends, competition, and strategic initiatives.
Recent Initiatives: Recent strategic initiatives may include focusing on core service lines, improving operational efficiency, and investing in technology.
Summary
Pediatrix (formerly Mednax) is a major player in specialized physician services, particularly neonatology and maternal-fetal medicine. The company has established a strong national presence. High debt levels are a concern, and future success depends on strategic execution and adapting to healthcare industry changes. The company's rebranding and new focus is a good sign of changes to come.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates
- News Articles
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate and may vary. Financial data is based on publicly available information and is subject to change. The AI-based rating is based on a limited set of information and should not be the sole basis for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mednax Inc
Exchange NYSE | Headquaters Sunrise, FL, United States | ||
IPO Launch date 1995-09-19 | CEO & Executive Chairman Mr. Mark S. Ordan | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 4120 | Website https://www.pediatrix.com |
Full time employees 4120 | Website https://www.pediatrix.com | ||
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in hospitals, pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.